ALNY
Alnylam Pharmaceuticals Inc
Price:  
150.03 
USD
Volume:  
655,697.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Alnylam Relative Valuation

-124.3%
Upside

As of 2024-05-30, the Relative Valuation of Alnylam Pharmaceuticals Inc (ALNY) is (36.42) USD. This relative valuation is based on P/E multiples. With the latest stock price at 150.03 USD, the upside of Alnylam Pharmaceuticals Inc based on Relative Valuation is -124.3%.

The range of the Relative Valuation is (33.02) - (39.27) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 12.6x - 16.1x 14.4x
Forward P/E multiples 11.8x - 15.0x 13.4x
Fair Price (33.02) - (39.27) (36.42)
Upside -122.0% - -126.2% -124.3%
150.03 USD
Stock Price
(36.42) USD
Fair Price

Alnylam Relative Valuation - Historical P/E Data

Date P/E
2024-05-30 -57.16
2024-05-29 -55.98
2024-05-28 -57.17
2024-05-24 -56.29
2024-05-23 -56.91
2024-05-22 -57.49
2024-05-21 -57.00
2024-05-20 -57.24
2024-05-17 -56.92
2024-05-16 -57.61
2024-05-15 -56.16
2024-05-14 -56.34
2024-05-13 -57.11
2024-05-10 -57.33
2024-05-09 -57.67
2024-05-08 -58.02
2024-05-07 -58.80
2024-05-06 -57.61
2024-05-03 -58.04
2024-05-02 -57.27
2024-05-01 -57.13
2024-04-30 -54.84
2024-04-29 -56.14
2024-04-26 -54.60
2024-04-25 -54.75
2024-04-24 -54.79
2024-04-23 -55.65
2024-04-22 -55.54
2024-04-19 -55.02
2024-04-18 -55.30
2024-04-17 -55.37
2024-04-16 -55.90
2024-04-15 -56.27
2024-04-12 -56.58
2024-04-11 -57.94
2024-04-10 -58.07
2024-04-09 -59.40
2024-04-08 -59.45
2024-04-05 -58.50
2024-04-04 -57.71
2024-04-03 -57.46
2024-04-02 -57.54
2024-04-01 -58.42
2024-03-28 -56.94
2024-03-27 -58.82
2024-03-26 -57.90
2024-03-25 -57.94
2024-03-22 -55.82
2024-03-21 -55.86
2024-03-20 -56.38